Continuing the Conversation: Exploring B-cell Maturation Antigen-Targeted Therapies and Managed Care Considerations for Patients With Multiple Myeloma | PTCE Pharmacy Connect

Educational Objectives

• Discuss the differing classes of B-cell maturation antigen-directed therapy for multiple myeloma
• Study the economic burden of multiple myeloma and cost-effective treatment strategies for B-cell maturation antigen-directed treatments

Faculty:

Joseph A. Kalis, PharmD, BCOP

Ambulatory Oncology Pharmacist

UCHealth Hematology/Oncology

Colorado Springs, Colorado

 

Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Director, Pharmacy Cancer Care

Department of Pharmacy

Mayo Clinic

 

Assistant Professor of Pharmacy

Mayo Clinic College of Medicine and Sciences

Rochester, Minnesota

 

Joseph A. Kalis, PharmD, BCOP, has the following financial relationships with commercial interests to disclose:
Speakers Bureau: Oncopeptides, GSK

Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, has the following financial relationships with commercial interests to disclose:
Grant/Research Support: AstraZeneza, Janssen

Consultant: BeiGene

Speakers Bureau: Pfizer

 

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-359-H01-P. The activity is available for CE credit through July 29, 2023.

 

This educational activity is supported by an educational grant from GlaxoSmithKline.